JP5224707B2 - 抗血小板膜糖蛋白質ｖｉモノクローナル抗体 - Google Patents

抗血小板膜糖蛋白質ｖｉモノクローナル抗体 Download PDF

Info

Publication number
JP5224707B2
JP5224707B2 JP2007078649A JP2007078649A JP5224707B2 JP 5224707 B2 JP5224707 B2 JP 5224707B2 JP 2007078649 A JP2007078649 A JP 2007078649A JP 2007078649 A JP2007078649 A JP 2007078649A JP 5224707 B2 JP5224707 B2 JP 5224707B2
Authority
JP
Japan
Prior art keywords
gpvi
antibody
human
mouse
rat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007078649A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007295926A5 (https=
JP2007295926A (ja
Inventor
博史 高山
嘉門 白川
正司 古迫
義隆 保坂
朋和 松末
克紀 内藤
ゆみ 堀田
哲史 川原
元康 本田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2006/301818 external-priority patent/WO2006117910A1/ja
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP2007078649A priority Critical patent/JP5224707B2/ja
Publication of JP2007295926A publication Critical patent/JP2007295926A/ja
Publication of JP2007295926A5 publication Critical patent/JP2007295926A5/ja
Application granted granted Critical
Publication of JP5224707B2 publication Critical patent/JP5224707B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2007078649A 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体 Expired - Fee Related JP5224707B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007078649A JP5224707B2 (ja) 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2005132665 2005-04-28
JP2005132665 2005-04-28
JP2005348534 2005-12-01
JP2005348534 2005-12-01
JPPCT/JP2006/301818 2006-01-27
PCT/JP2006/301818 WO2006117910A1 (ja) 2005-04-28 2006-01-27 抗血小板膜糖蛋白質ⅵモノクローナル抗体
JP2007078649A JP5224707B2 (ja) 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007514878A Division JP4185555B2 (ja) 2005-04-28 2006-04-28 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Publications (3)

Publication Number Publication Date
JP2007295926A JP2007295926A (ja) 2007-11-15
JP2007295926A5 JP2007295926A5 (https=) 2011-05-19
JP5224707B2 true JP5224707B2 (ja) 2013-07-03

Family

ID=38765971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007078649A Expired - Fee Related JP5224707B2 (ja) 2005-04-28 2007-03-26 抗血小板膜糖蛋白質ｖｉモノクローナル抗体

Country Status (1)

Country Link
JP (1) JP5224707B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009284771A (ja) * 2008-05-27 2009-12-10 Takara Bio Inc 抗体産生細胞の作製方法
CA2784498A1 (en) * 2009-12-18 2011-06-23 Sanofi Novel antagonist antibodies and their fab fragments against gpvi and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302706B6 (cs) * 1998-12-23 2011-09-14 Pfizer Inc. Lidská monoklonální protilátka, farmaceutická kompozice tuto protilátku obsahující, bunecná linie produkující tuto protilátku, izolovaná molekula kódující težký nebo lehký retezec uvedené protilátky, hostitelská bunka obsahující tuto izolovanou molek
KR100453877B1 (ko) * 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
PT2308888T (pt) * 2001-11-14 2017-05-03 Janssen Biotech Inc Anticorpos anti-il-6, composições, métodos e utilizações
EP1369128A1 (en) * 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
BRPI0315295C1 (pt) * 2002-10-17 2021-05-25 Genmab As anticorpo monoclonal humano isolado, célula hospedeira procariótica, composição farmacêutica, molécula biespecífica, usos de um anticorpo, métodos in vitro de detectar a presença de antígeno de cd20 ou uma célula que expressa cd20 em uma amostra, kit, e, vetor de expressão
EP1633860A2 (en) * 2003-06-09 2006-03-15 Wyeth IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
AU2004266242A1 (en) * 2003-08-12 2005-03-03 Dyax Corp. Tie1-binding ligands

Also Published As

Publication number Publication date
JP2007295926A (ja) 2007-11-15

Similar Documents

Publication Publication Date Title
JP4185555B2 (ja) 抗血小板膜糖蛋白質ｖｉモノクローナル抗体
JP5843783B2 (ja) ＧＰＶＩに対する新規アンタゴニスト抗体および該抗体のＦａｂフラグメントならびにこれらの使用
US8541565B2 (en) Polynucleotide encoding anti-CD14 antibody fusion protein
US8236315B2 (en) Humanized antibodies specific for von Willebrand factor
JP5184367B2 (ja) 抗アルファ２インテグリン抗体およびその使用
US20070025992A1 (en) Monoclonal antibody against platelet membrane glycoprotein VI
EP1876240B1 (en) Anti-human platelet membrane glycoprotein vi monoclonal antibody
AU2021202612B2 (en) Inhibition of platelet aggregation using anti-human GPVI antibodies
KR101604877B1 (ko) 항ａｄａｍ－１５항체 및 그의 이용
JP5224707B2 (ja) 抗血小板膜糖蛋白質ｖｉモノクローナル抗体
CN113631188A (zh) 抗pd-l1结合蛋白及其使用方法
EP4431526A1 (en) Anti-gpvi antibodies and functional fragments thereof

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090423

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090423

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20100305

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100305

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110906

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120313

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120511

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121120

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130121

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130312

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160322

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees